<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04147481</url>
  </required_header>
  <id_info>
    <org_study_id>PLAGHAOC1901</org_study_id>
    <nct_id>NCT04147481</nct_id>
  </id_info>
  <brief_title>Effects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal Surgery</brief_title>
  <official_title>Effects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yi Liu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the effect of general anesthesia combined with transversus abdominis plane block
      (TAPB) and/or rectus sheath block (RSB) on the recovery of patients with gastrointestinal
      tumor after surgical treatment.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 21, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative chronic pain</measure>
    <time_frame>6 month after operation</time_frame>
    <description>The incidence of chronic pain 6 month after operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bedridden time</measure>
    <time_frame>The postoperative duration up to 15 days</time_frame>
    <description>Postoperative bedridden time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting time</measure>
    <time_frame>The postoperative duration up to 15 days</time_frame>
    <description>Postoperative fasting time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal decompression</measure>
    <time_frame>The postoperative duration up to 15 days</time_frame>
    <description>Time of gastrointestinal decompression</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The numeric rating scale of postoperative pain</measure>
    <time_frame>Within 7 days after surgery</time_frame>
    <description>The numerical rating scale (0-10) of posteoperaitve acute pain. If the NRS was larger than 4, we must take emergency action, including pressuring patient controlled analgesia pump, giving other analgesics.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Colon Cancer</condition>
  <condition>Rectal Cancer</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Group Abdominal Nerve Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>surgical under general anesthesia combined with transversus abdominis plane block (TAPB) and/or rectus sheath block (RSB) with 0.2% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>surgical under general anesthesia combined with transversus abdominis plane block (TAPB) and/or rectus sheath block (RSB) with 0.9% saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group Abdominal Nerve Block with local anesthetics</intervention_name>
    <description>surgical under general anesthesia combined with transversus abdominis plane block (TAPB) and/or rectus sheath block (RSB) with 0.2% ropivacaine</description>
    <arm_group_label>Group Abdominal Nerve Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group Abdominal Nerve Block with saline</intervention_name>
    <description>surgical under general anesthesia combined with transversus abdominis plane block (TAPB) and/or rectus sheath block (RSB) with not 0.2% ropivacaine but 0.9% saline.</description>
    <arm_group_label>Group control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 18 to 80 years.

          2. ASA 1-3.

          3. Clinical diagnosis of gastric carcinoma and colorectal cancer without metastasis.

          4. Surgery for gastrointestinal surgery.

        Exclusion Criteria:

          1. Patients and their family members refuse to accept the clinical trial;

          2. Complicated with acute cholangitis, gastrointestinal bleeding or ascites, etc.;

          3. Hepatic encephalopathy, psychosis or neuropathy;

          4. Body weight for acid-base and electrolyte imbalances, endotoxemia, and cachexia
             decreased by more than 2% or 5% in the past 2 months or 6 months.

          5. Uncontrolled hypertentsion, coronary heart disease, diabetes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Liu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>the Chinese PLA General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Haidian</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 19, 2019</study_first_submitted>
  <study_first_submitted_qc>October 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2019</study_first_posted>
  <last_update_submitted>November 9, 2019</last_update_submitted>
  <last_update_submitted_qc>November 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Yi Liu</investigator_full_name>
    <investigator_title>Attending doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

